United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$543.66 for US$5.16M under a trading plan, leaving 40,513 shares. Filed Jul 2, 2026 (Form 4).

Sold
9,500 shares
Price
US$543.66 average (US$537.58 to US$549.14)
Value
US$5.16M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jul 1, 2026Common StockSale405US$537.5849,608Direct
Jul 1, 2026Common StockSale818US$539.0948,790Direct
Jul 1, 2026Common StockSale1,524US$539.9247,266Direct
Jul 1, 2026Common StockSale773US$540.9246,493Direct
Jul 1, 2026Common StockSale880US$542.1545,613Direct
Jul 1, 2026Common StockSale520US$543.1645,093Direct
Jul 1, 2026Common StockSale880US$545.0044,213Direct
Jul 1, 2026Common StockSale1,124US$546.4643,089Direct
Jul 1, 2026Common StockSale969US$547.4042,120Direct
Jul 1, 2026Common StockSale1,221US$548.2140,899Direct
Jul 1, 2026Common StockSale386US$549.1440,513Direct

Source

View original at SEC

Related